Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-004 - Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status
09:30 - 09:30 | Presenter: Hirotsugu Kenmotsu | Author(s): E. Iwama, Yasushi Goto, T. Harada, S. Tsumura, H. Sakashita, Y. Mori, N. Nakagaki, Y. Fujita, M. Seike, A. Bessho, M. Ono, A. Okazaki, H. Akamatsu, R. Morinaga, S. Ushijima, T. Shimose, S. Tokunaga, A. Hamada, Nobuyuki Yamamoto, Yoichi Nakanishi, K. Sugio, Isamu Okamoto
- Abstract
Loading... -
+
P1.03-038 - A Phase I Trial of Afatinib and Bevacizumab in Untreated Patients with Advanced NSCLC Harboring EGFR-Mutations: OLCSG1404
09:30 - 09:30 | Presenter: Shoichi Kuyama | Author(s): Kenichiro Kudo, T. Tamura, T. Nishi, Daijiro Harada, A. Bessho, N. Fujimoto, D. Minami, K. Aoe, T. Ninomiya, K. Kiura
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-034 - Phase I/II Trial of Weekly Nab-Paclitaxel as 2nd or 3rd Line Treatment in NSCLC Without Driver Mutations. (OLCSG1303)
09:00 - 09:00 | Presenter: Kenichiro Kudo | Author(s): Shoichi Kuyama, Daijiro Harada, T. Kozuki, A. Bessho, K. Hotta, H. Yoshioka, K. Gemba, N. Takigawa, I. Oze, K. Kiura
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-045 - Updated Results of Phase II, Liquid Biopsy Study in EGFR Mutated NSCLC Patients Treated with Afatinib (WJOG 8114LTR)
09:30 - 09:30 | Presenter: Hidetoshi Hayashi | Author(s): H. Akamatsu, Y. Koh, S. Morita, Daichi Fujimoto, Isamu Okamoto, A. Bessho, K. Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto
- Abstract
Loading...
-
+
OA 12 - Emerging Genomic Targets
- 11:00 - 12:30
- 10/18/2017
- Location: F203 + F204 (Annex Hall)
- Type: Oral
- Track: Advanced NSCLC
- Moderators:H. Akita, Maurice Pérol
-
+
OA 12.03 - Clinical Features of Advanced Lung Cancer Harboring HER2 Aberrations: A Large Prospective Cohort Study (HER2-CS STUDY)
11:20 - 11:30 | Presenter: Shinobu Hosokawa | Author(s): A. Bessho, K. Ninomiya, T. Tanaka, N. Ishikawa, M. Yamasaki, T. Shibayama, K. Aoe, T. Kozuki, N. Fujimoto, K. Gemba, Y. Ueda, M. Inoue, T. Murakami, Shoichi Kuyama, H. Kawai, K. Fujitaka, K. Inoue, M. Takata, H. Yanai, K. Hotta, K. Kiura
- Abstract
Loading...